Skip to main content

Data & APIs
Events
Cannabis
Marketfy
Premarket Prep

+

Create your free account

Already have an account? Login

Name:

Email Address:

Password:

Leave blank:

By creating an account, you agree to the
Terms of Service and acknowledge our Privacy Policy.

+

Log in to your account

Email Address:

Password:

Forgot your password?

Don't have a Benzinga account? Create one

Contribute
Login
Join

News
- Earnings
- Guidance
- Dividends
- M&A
- Buybacks
- Legal
- Interviews
- Management
- Retail Sales
- Offerings
- IPOs
- Insider Trades
- Biotech/FDA
- Freight
- Tech
Markets
- Pre-Market
- After Hours
- Movers
- ETFs
- Forex
- Cannabis
- Commodities
- Options
- Binary Options
- Bonds
- Futures
- Global Economics
- Previews
- Reviews
- Small-Cap
- Cryptocurrency
- Penny Stocks
Ratings
Ideas
Fintech
Investing
Cannabis
Education
Premium

Market Overview

Tickers, Articles and Keywords:

Tickers

Articles

Keywords

Search by keyword...

googlecse

More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries

Cogent Biosciences, Inc. (COGT)

7.84 -0.36 (-4.39%)

Analyst Ratings

Find Analyst Ratings for:

Date	Research Firm	Action	Current	PT
12/23/20	Piper Sandler	Initiates Coverage On	Overweight	22.0
12/16/20	SVB Leerink	Initiates Coverage On	Outperform	20.0
10/14/20	Ladenburg Thalmann	Initiates Coverage On	Buy	4.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter

Recent Ratings

CM (Upgrades)
SHNWF (Upgrades)
ICLR (Upgrades)
MNST (Upgrades)
USPH (Downgrades)
MGPI (Downgrades)
GFL (Downgrades)
EDIT (Downgrades)
CLW (Downgrades)
IRTC (Downgrades)

News Coverage

When You Buy A Stock, Here's How Much Cash The Company Actually Receives
RBC: Keurig Dr Pepper Growth 'Gets Another Jolt', 'Monster' Results From Monster Beverage
Why GameStop Stock Traders Should Beware The 'Law Of Twos And Threes'
4 Workday Analysts Break Down Earnings, Look Ahead To Fiscal 2022
Rocket Companies 'Firing On All Cylinders,' BofA Says After Q4 Print
JPMorgan Strategists Suggest 1% Crypto Allocation To Clients
4 Airbnb Stock Analysts On Q4 Results, 2021 Outlook: 'The Best Way To Play A Travel Recovery'
Morgan Stanley Upgrades Carvana As It Targets New Markets, Nearly Doubles Price Target
What's In Store for L Brands With Morgan Stanley Upgrade?
Why BofA Is Bearish On GameStop Stock: 'Turnarounds Are Tough'

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
News Widget
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Privacy Policy / Do Not Sell My Personal Data
Disclaimer
Service Status
Sitemap

© 2021 Benzinga | All Rights Reserved